Magnetic Resonance Imaging (MRI) Staging of Cervix Cancer

Completed

Conditions studied: Cancer of the Uterine Cervix

In brief

The researchers propose that it may be corpus invasion, rather than tumour volume per se, which is one of the important determinants of ultimate outcome in cervix cancer. The aim of the proposed prospective, multicentre study, is to confirm the results of our retrospective studies, specifically that corpus invasion or tumour volume or both contribute important prognostic information over and above that provided by the currently used International Federation of Gynecology and Obstetrics (FIGO) staging system. A successful outcome would have important implications for the staging, and management as well as the biologic understanding of the behaviour of cervical cancer.

Key facts

Study ID

NCT00193934

Run by

Trans Tasman Radiation Oncology Group

People needed

109

Starts

2006-01-01

Expected to finish

2014-05-15

Last updated by the study team

2017-07-12

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Newly diagnosed, biopsy proven carcinoma of the uterine cervix.
• Squamous cell, adenocarcinoma, adenosquamous or large cell carcinoma histology.
• FIGO Stage Ib -IVa.
• Maximum clinical tumour diameter recorded.
• MRI done within 30 days prior to registration.
• Intention to treat radically
• Treatment not yet started.
• Written informed consent.
• Available for follow-up.

You may not qualify if…

• Lymphoma, small cell carcinoma and melanoma histology.
• Previous hysterectomy
• Pregnancy

Where it is running

• Washington University School of Medicine — St Louis, Missouri, United States
• Liverpool Hospital — Liverpool, New South Wales, Australia
• Calvary Mater Newcastle — Newcastle, New South Wales, Australia
• Royal North Shore Hospital — Sydney, New South Wales, Australia
• Westmead Hospital — Wentworthville, New South Wales, Australia
• Royal Brisbane Hospital — Herston, Queensland, Australia
• North Queensland Oncology Service — Townsville, Queensland, Australia
• Premion - Tugun — Tugun, Queensland, Australia
• Royal Adelaide Hospital — Adelaide, South Australia, Australia
• Peter MacCallum Cancer Centre — Melbourne, Victoria, Australia
• Tata Memorial Hospital — Mumbai, India
• Meenakshi Mission Hospital — Tamil Nadu, India
• Auckland Hospital — Auckland, New Zealand
• Christchurch Hospital — Christchurch, New Zealand
• Dunedin Hospital — Dunedin, New Zealand
• National University Hospital — Singapore, Singapore

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.